🌟 Introducing MINDSAI: Revolutionizing Mental Healthcare Through Biomarker Innovation

MINDSAI is pioneering the integration of biotechnology in mental healthcare, and we're excited to showcase two revolutionary products:

🔬 Our Flagship Solutions:
- Minds.NAVI - The world's first depression screening solution combining salivary biomarkers with psychological assessment
- 97.22% sensitivity
- 95.24% specificity
- Non-invasive, accessible technology

🎯 CHEEU.Forest - Revolutionary VR-based digital therapeutic
- 48% reduction in depressive symptoms
- 54% reduction in suicide risk within 6 weeks
- Clinically validated treatment approach

🏆 Led by Expert Team:
- Dr. Seok Jeong-Ho (CEO)
 - Psychiatrist, Professor at Yonsei University College of Medicine
- Dr. Jang Soo-Ah (Research Director)
 - Psychiatrist, Adjunct Professor at Yonsei University College of Medicine
- Shin HyunKyung (Senior Researcher)
 - Clinical psychologist specializing in mental health diagnostics

💫 Visit Us at CES 2025!
We invite you to experience our groundbreaking mental health solutions in person:
📍 Las Vegas Venetian Expo
🔍 Booth #62817-25, Hall G(1F), Eureka Park
📅 January 7-10, 2025

Schedule a meeting with our team to discover how we're transforming mental healthcare!

🔗 Learn more about our innovative solutions:
- CES Landing Page: https://mindsai.co.kr/ces
- Schedule a Meeting: https://mindsai.co.kr/ces/reservation
- Media Kit: https://bit.ly/3DHvQho

Join us in transforming mental healthcare through cutting-edge technology and innovative diagnostics.

#MentalHealth #HealthTech #Innovation #BioTechnology #CES2025 #Depression #DigitalHealth #Healthcare #MedTech #AI

For inquiries:
📧 hkshin0716@mindsai.co.kr
📧 ahyunia@mindsai.co.kr

MINDSAI

Org chart

Teams

Offices